Theranos
Top Five Articles on 360Dx Last Week: Dx Companies' Plans for POC Testing; IVDR Rollout; More
Last week, readers were most interested in a story about the hurdles faced by companies bringing routine testing at the point of care.
Theranos Prepares to Shut Down
In an email, the company's CEO said it is running out of funds and has been unable to find new investors — the shutdown could start on Sept. 10.
Sight Diagnostics Launches POC System for Complete Blood Count in Europe With Plans for US Market
Premium
Having achieved CE marking, the new OLO system has launched in Europe and non-US countries, while the company is conducting studies necessary for US FDA clearance.
Theranos' Holmes and Balwani Indicted For Alleged Wire Fraud Schemes
Elizabeth Holmes also stepped down from her position as Theranos CEO on Friday, to be replaced by the company's general counsel David Taylor.
SEC Charges Theranos, CEO Holmes, Former President Balwani With Fraud
Company Founder and CEO Elizabeth Holmes has agreed to pay a $500,000 penalty. She is also barred from serving as an officer or director of a publicly traded company for 10 years.